IIT researchers develop promising TB diagnostics solution
Ravi Elangovan’s decision to leave a cushy research job in Florence and join IIT-Delhi’s faculty in 2010 was driven mostly by personal reasons.
Johnson and Johnson to offer first TB drug in 40 years for $900
US drug maker Johnson and Johnson will offer its new tuberculosis (TB) drug, Bedaquiline, at $900 (Rs 70,000) once its conditional access programme with the government of India ends in 2019, the company said in an interview to ET.